Ardent Health, Inc. (NYSE:ARDT – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Friday. The company traded as high as $16.31 and last traded at $16.4310, with a volume of 147,072 shares trading hands. The stock had previously closed at $15.90.
Analysts Set New Price Targets
ARDT has been the topic of several recent research reports. Weiss Ratings upgraded shares of Ardent Health from a “sell (d)” rating to a “sell (d+)” rating in a research note on Tuesday, October 6th. Royal Bank Of Canada boosted their target price on shares of Ardent Health from $12.00 to $13.00 and gave the company an “outperform” rating in a research report on Monday, August 10th. BMO Capital Markets began coverage on shares of Ardent Health in a research report on Tuesday, September 22nd. They set a “market perform” rating and a $11.00 target price for the company. Guggenheim upped their target price on shares of Ardent Health from $13.00 to $14.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Finally, Leerink Partners reiterated an “outperform” rating and issued a $14.00 price target on shares of Ardent Health in a research report on Friday, September 18th. Seven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $12.79.
Check Out Our Latest Report on Ardent Health
Ardent Health Stock Up 9.1%
The company has a 50-day moving average of $11.32 and a two-hundred day moving average of $10.05. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.10 and a quick ratio of 1.99. The company has a market capitalization of $2.45 billion, a PE ratio of 16.85, a P/E/G ratio of 3.68 and a beta of 0.58.
Ardent Health (NYSE:ARDT – Get Free Report) last issued its quarterly earnings results on Wednesday, November 4th. The company reported $0.31 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.08. Ardent Health had a return on equity of 8.49% and a net margin of 2.27%. The business had revenue of $1.62 billion during the quarter, compared to analysts’ expectations of $1.60 billion. Sell-side analysts anticipate that Ardent Health, Inc. will post 0.96 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Ardent Health
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in Ardent Health during the 2nd quarter worth approximately $21,415,000. Algert Global LLC lifted its holdings in Ardent Health by 1,277.3% during the second quarter. Algert Global LLC now owns 597,745 shares of the company’s stock valued at $5,882,000 after purchasing an additional 554,345 shares in the last quarter. Empowered Funds LLC bought a new position in shares of Ardent Health in the second quarter worth approximately $5,425,000. First Trust Advisors LP boosted its position in shares of Ardent Health by 70.9% in the first quarter. First Trust Advisors LP now owns 478,795 shares of the company’s stock worth $4,098,000 after purchasing an additional 198,595 shares during the period. Finally, Bank of America Corp DE bought a new position in shares of Ardent Health in the second quarter worth approximately $3,840,000.
Ardent Health Company Profile
Ardent Health is a U.S. healthcare services company that operates hospitals, outpatient facilities and physician practices. Its services include emergency and acute care, surgery, cardiology, orthopedics, oncology, women’s health, behavioral health, rehabilitation, imaging and other specialty and primary care offerings.
The company serves patients through regional health networks and hospital campuses primarily in Texas, Oklahoma, New Mexico and other U.S. markets. In addition to hospital-based care, Ardent operates outpatient clinics, urgent care locations and other facilities designed to provide services across different stages of the patient-care process.
Ardent Health was founded in 2001 and became a publicly traded company on the New York Stock Exchange in 2024.
Featured Articles
- Five stocks we like better than Ardent Health
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
- Block by Block: Cash App Builds a Stronger Foundation
- Arista Networks Cashes In on the AI Infrastructure Buildout
- Powering Up: Freeport-McMoRan’s $4.5B Copper Expansion
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
